Publications

On December 18, 2026, an online meeting was held to discuss the new Law of Ukraine "On Veterinary Medicine" regarding the import and distribution of veterinary medicines.

This event launched a regular series of informational seminars, which will be held on an ongoing basis and will be open to all interested stakeholders.

At the same time, please note that in-depth discussions, practical case reviews and extended Q&A sessions will be conducted exclusively for members of the Ukrainian Veterinary Alliance.

Key dates to note

• March 1, 2026 — the Law enters into force

Transitional periods include:

• licensing for import and wholesale trade — until September 1, 2027
• licensing for retail trade — until March 1, 2028
• batch release testing:
• in Ukraine — starting March 1, 2026
• acceptance of batch release results from PIC/S member countries — until July 1, 2027
• submission of documents in paper form — until March 1, 2030
• submission of documents for inclusion of operators importing, manufacturing and/or distributing active substances — within 6 months from the Law’s entry into force.

Definitions and terms (English unofficial translation)

1. Market operator – a food business operator, feed business operator, operator in the field of handling animal by-products, veterinary medicinal products market operator, operator of facilities where animals are kept;
2. Veterinary medicinal products market operator – a business entity included in the State Register of Veterinary Medicinal Products Market Operators;
3. Good Manufacturing Practice (GMP) – a part of the quality assurance system which ensures that products are consistently produced and controlled in accordance with quality standards and in line with their intended use;
4. Good Distribution Practice (GDP) for veterinary medicinal products – a part of the quality assurance system within the supply chain which ensures that the quality of veterinary medicinal products is maintained at all stages of the supply chain:

• starting from the manufacturing site of a veterinary medicinal products market operator engaged in the manufacture of a veterinary medicinal product, to a veterinary medicinal products market operator engaged in wholesale distribution and/or to a veterinary medicinal products market operator engaged in retail sale of veterinary medicinal products, provided that they purchase veterinary medicinal products directly from the market operator engaged in the manufacture of the veterinary medicinal product;
• starting from a veterinary medicinal products market operator engaged in wholesale distribution, to a veterinary medicinal products market operator engaged in retail sale of veterinary medicinal products, and/or to a licensed veterinarian or a licensed veterinary medicine establishment, provided that they purchase veterinary medicinal products directly from the market operator engaged in wholesale distribution;

5. Good Distribution Practice of active substances used as raw materials for the manufacture of veterinary medicinal products – a part of the quality assurance system within the supply chain which ensures that the quality of active substances used as raw materials for the manufacture of veterinary medicinal products is maintained at all stages of the supply chain – from the manufacturing site of a veterinary medicinal products market operator engaged in the manufacture of the active substance, to the manufacturing site of a veterinary medicinal products market operator engaged in the manufacture of the veterinary medicinal product;
6. Good Clinical Practice (GCP) – a set of detailed ethical and scientific quality requirements for the design, management, conduct, monitoring, auditing, documentation, analysis and reporting of clinical trials, which ensure the protection of the rights, safety and well-being of clinical trial subjects, as well as the reliability and credibility of data obtained in a clinical trial;
7. Good Laboratory Practice (GLP) – a quality system concerned with the organizational process and conditions under which non-clinical safety studies for human health and the environment are planned, performed, monitored, documented, archived and reported.

Adopted secondary legislation

1. Qualification requirements for the Qualified Person responsible for manufacturing and import - https://zakon.rada.gov.ua/laws/show/z1423-23#n19
2. Procedure for submission of information on sales volumes of veterinary medicinal products - https://zakon.rada.gov.ua/laws/show/z1424-23#n4

Potential risks

A key challenge remains the lack of secondary legislation defining GMP requirements, inspection procedures, and licensing rules and requirements.

The Alliance will continue communication with the Ministry of Economy, environment and agriculture of Ukraine, the State Service of Ukraine on Food Safety and Consumer Protection, and Members of Parliament to help ensure clear and predictable procedures for both business and the state.

Invitation to cooperate and join the Alliance

The Ukrainian Veterinary Alliance remains open to cooperation and dialogue. We invite you to join the Alliance and actively contribute to shaping a transparent and predictable regulatory environment for veterinary medicine in Ukraine.

Contacts:

https://vetalliance.org.ua/

[email protected]

Kind regards,

Ukrainian Veterinary Alliance